Thomas P. Slavin

2.9k total citations
44 papers, 917 citations indexed

About

Thomas P. Slavin is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Thomas P. Slavin has authored 44 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 18 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Thomas P. Slavin's work include Cancer Genomics and Diagnostics (16 papers), BRCA gene mutations in cancer (13 papers) and Genetic factors in colorectal cancer (12 papers). Thomas P. Slavin is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), BRCA gene mutations in cancer (13 papers) and Genetic factors in colorectal cancer (12 papers). Thomas P. Slavin collaborates with scholars based in United States, United Kingdom and Mexico. Thomas P. Slavin's co-authors include Jeffrey N. Weitzel, Stacy W. Gray, Muhammed Murtaza, Ajay Goel, Prativa Sahoo, Russell C. Rockne, Laura H. Goetz, Colin C. Pritchard, Nicholas J. Schork and Robert C. Elston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas P. Slavin

43 papers receiving 894 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas P. Slavin United States 16 404 387 262 255 166 44 917
Joseph Vijai United States 16 298 0.7× 332 0.9× 489 1.9× 202 0.8× 128 0.8× 62 976
Lidia Rita Corsini Italy 19 323 0.8× 430 1.1× 180 0.7× 381 1.5× 164 1.0× 41 892
Sarah M. Nielsen United States 16 340 0.8× 255 0.7× 329 1.3× 273 1.1× 147 0.9× 75 882
Lisa Golmard France 17 139 0.3× 345 0.9× 362 1.4× 231 0.9× 218 1.3× 51 873
Obul Reddy Bandapalli Germany 19 221 0.5× 501 1.3× 111 0.4× 401 1.6× 80 0.5× 47 1.3k
Synnöve Staff Finland 20 172 0.4× 454 1.2× 158 0.6× 429 1.7× 79 0.5× 48 1.2k
Beth O. Van Emburgh United States 9 165 0.4× 664 1.7× 132 0.5× 223 0.9× 83 0.5× 10 922
Federica Torricelli Italy 18 212 0.5× 471 1.2× 137 0.5× 208 0.8× 241 1.5× 80 1.0k
М. В. Немцова Russia 15 266 0.7× 556 1.4× 104 0.4× 183 0.7× 105 0.6× 93 885

Countries citing papers authored by Thomas P. Slavin

Since Specialization
Citations

This map shows the geographic impact of Thomas P. Slavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas P. Slavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas P. Slavin more than expected).

Fields of papers citing papers by Thomas P. Slavin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas P. Slavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas P. Slavin. The network helps show where Thomas P. Slavin may publish in the future.

Co-authorship network of co-authors of Thomas P. Slavin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas P. Slavin. A scholar is included among the top collaborators of Thomas P. Slavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas P. Slavin. Thomas P. Slavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Whitaker, Regina S., Shonagh Russell, Benjamin B. Albright, et al.. (2023). Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous Carcinoma. Cancers. 15(2). 528–528. 1 indexed citations
2.
Castillo, Danielle, Bita Nehoray, Kai Yang, et al.. (2022). Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status. Cancer Epidemiology Biomarkers & Prevention. 31(8). 1621–1629. 7 indexed citations
3.
Gallagher, Shannon, Elisha Hughes, Allison W. Kurian, et al.. (2021). Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model. JCO Precision Oncology. 5(5). 1073–1081. 14 indexed citations
4.
Kwong, Ava, Vivian Y. Shin, Chun Hang Au, et al.. (2020). Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients. BMC Cancer. 20(1). 1053–1053. 8 indexed citations
5.
Weitzel, Jeffrey N., Susan L. Neuhausen, Aaron W. Adamson, et al.. (2019). Pathogenic and likely pathogenic variants in PALB2 , CHEK2 , and other known breast cancer susceptibility genes among 1054 BRCA ‐negative Hispanics with breast cancer. Cancer. 125(16). 2829–2836. 36 indexed citations
6.
Chávarri-Guerra, Yanin, Carolyn B. Hendricks, Sandra M. Brown, et al.. (2019). The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients. Journal of the American Geriatrics Society. 67(5). 884–888. 10 indexed citations
7.
Slavin, Thomas P., Jennifer Berano Teh, Jeffrey N. Weitzel, et al.. (2019). Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(12). 2517–2521. 18 indexed citations
8.
McDonald, Bradon R., Tania Contente‐Cuomo, Stephen‐John Sammut, et al.. (2019). Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer. Science Translational Medicine. 11(504). 201 indexed citations
9.
Weitzel, Jeffrey N., Prativa Sahoo, Russell C. Rockne, et al.. (2019). Circulating tumor DNA as an early cancer detection tool. Pharmacology & Therapeutics. 207. 107458–107458. 156 indexed citations
10.
Ghosh, Pradipta, et al.. (2019). Novel candidates in early-onset familial colorectal cancer. Familial Cancer. 19(1). 1–10. 16 indexed citations
11.
Slavin, Thomas P., Can‐Lan Sun, Yanin Chávarri-Guerra, et al.. (2019). Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis. Journal of Geriatric Oncology. 11(2). 316–319. 9 indexed citations
12.
Slavin, Thomas P., Bradford Coffee, Ryan Bernhisel, et al.. (2019). Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing. Cancer Genetics. 235-236. 31–38. 24 indexed citations
13.
Solomon, Ilana, Kathleen R. Blazer, Bita Nehoray, et al.. (2018). Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family Conference. Journal of Cancer Education. 34(6). 1204–1212. 1 indexed citations
14.
Young, David, et al.. (2013). Expanding the BP1-BP2 15q11.2 Microdeletion Phenotype: Tracheoesophageal Fistula and Congenital Cataracts. SHILAP Revista de lepidopterología. 2013. 1–3. 15 indexed citations
15.
Slavin, Thomas P., et al.. (2013). Genetic associations of relaxin: preterm birth and premature rupture of fetal membranes. American Journal of Obstetrics and Gynecology. 209(3). 258.e1–258.e8. 18 indexed citations
16.
17.
Slavin, Thomas P., et al.. (2012). Monozygotic twins discordant for trisomy 13. Journal of Perinatology. 32(4). 306–308. 17 indexed citations
18.
Repnikova, Elena, Caroline Astbury, Shalini C. Reshmi, et al.. (2012). Microarray comparative genomic hybridization and cytogenetic characterization of tissue‐specific mosaicism in three patients. American Journal of Medical Genetics Part A. 158A(8). 1924–1933. 17 indexed citations
19.
Slavin, Thomas P., Tao Feng, Audrey Schnell, Xiaofeng Zhu, & Robert C. Elston. (2011). Two-marker association tests yield new disease associations for coronary artery disease and hypertension. Human Genetics. 130(6). 725–733. 61 indexed citations
20.
Slavin, Thomas P. & Georgia L. Wiesner. (2009). Developmental defects and childhood cancer. Current Opinion in Pediatrics. 21(6). 717–723. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Vijai Breakdown of academic impact, for papers by Lidia Rita Corsini Breakdown of academic impact, for papers by Sarah M. Nielsen Breakdown of academic impact, for papers by Lisa Golmard Breakdown of academic impact, for papers by Obul Reddy Bandapalli Breakdown of academic impact, for papers by Synnöve Staff Breakdown of academic impact, for papers by Beth O. Van Emburgh Breakdown of academic impact, for papers by Federica Torricelli Breakdown of academic impact, for papers by М. В. Немцова
Rankless by CCL
2026